Harrow, Inc. (HROW)
33.28
-1.13
(-3.28%)
USD |
NASDAQ |
Mar 20, 16:00
33.32
+0.04
(+0.12%)
After-Hours: 20:00
Harrow Market Cap : 1.239B for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.685B |
| Esperion Therapeutics, Inc. | 654.87M |
| Regeneron Pharmaceuticals, Inc. | 77.48B |
| Theravance Biopharma, Inc. | 726.14M |
| Rhythm Pharmaceuticals, Inc. | 5.972B |
Market Cap Related Metrics
| PS Ratio | 4.607 |
| Price to Book Value | 23.62 |
| Price to Free Cash Flow | 29.34 |
| Price | 33.28 |
| Earnings Yield | -0.49% |
| Operating PE Ratio | 32.20 |
| Normalized PE Ratio | 246.70 |